HLN ConsultingInnovators in Health Informatics

Category Archives

61 Articles

HLN updates COVID-19 vaccine support for Pfizer pediatric dose in its Award Winning ICE Open Source Immunization Forecaster

Share

HLN updates COVID-19 vaccine support for Pfizer pediatric dose in its Award Winning ICE Open Source Immunization Forecaster

On November 24, 2021, HLN released a new version (v1.32.1) of the Immunization Calculation Engine (ICE) in support of updates to the COVID-19 vaccine. ICE is a state-of-the-art ope ...

On November 24, 2021, HLN released a new version (v1.32.1) of the Immunization Calculation Engine (ICE) in support of updates to the COVID-19 vaccine. ICE is a state-of-the-art open source software system that provides clinical decision support for immunizations for use in Immunization Information Systems (IIS), Electronic Health Record (EHR), and Personal Health Record (PHR) Systems.

Version 1.32.1 includes the following additions and updates. Please see the Release Notes for details.

  • COVID-19 Updates:
    • COVID-19 Pfizer Pediatric Dose (5 through 11 years old)
    • Evaluation of Janssen booster dose as Valid
    • Added COVAXIN (CVX 502) as a WHO-approved vaccine for EUA
  • An updated Implementation Guide with the following new codes:
    • CVX 218 – vaccine code for the COVID-19 Pfizer pediatric vaccine
    • BOOSTER_DOSE – new recommendation reason code to indicate that the recommendation is for a booster dose

The full software release is available for download at https://cdsframework.atlassian.net/wiki/spaces/ICE/pages/18972704/Downloads 

Note about upcoming ICE release (scheduled December 2021)

  • As always, HLN is actively monitoring all news and updates in regards to new and existing COVID-19 vaccines. Currently, we are working on adding additional support and logic (based on latest published guidance) in ICE to handle the following:
    • Updated Booster Dose Rules
    • Updated Additional Dose Rules
    • Updated Absolute Minimum Intervals and Absolute Minimum Ages

Plans for COVID-19 Support in ICE

Once a vaccine has been approved for use by the FDA (either Expanded Access, EUA, or full licensure), the Advisory Committee on Immunization Practices (ACIP) will hold an emergency meeting and publish recommendations in a very quick time frame (i.e., days). HLN intends to release a version of ICE that includes updated COVID-19 forecasting as early as possible. The initial release will contain COVID-19 logic that is known at the time of the release. As additional, relevant information on COVID-19 becomes available from official sources, HLN will continue to release additional versions of ICE, at appropriate times.

If you have any questions, comments or suggestions, please e-mail us at ice@hln.com.

HLN’s Immunization Calculation Engine (ICE) chosen as a Digital Public Goods Standard

Share

HLN’s Immunization Calculation Engine (ICE) chosen as a Digital Public Goods Standard

HLN Consulting is thrilled to announce that the Immunization Calculation Engine (ICE) project has been chosen by the Digital Public Goods Alliance (DPGA) as innovative open technol ...

HLN Consulting is thrilled to announce that the Immunization Calculation Engine (ICE) project has been chosen by the Digital Public Goods Alliance (DPGA) as innovative open technology and listed in their Digital Public Goods registry. Technologies included in the list are considered to be digital public goods in alignment with the Digital Public Goods Standard. ICE now appears in the Digital Public Goods registry where it is discoverable as a digital public good and reflected on a growing network of catalogs and aggregated lists of digital public goods. The DPGA believes that sharing digital innovation is crucial to building a more equitable world.

HLN updates COVID-19 vaccine support for Pfizer booster dose in its Award Winning ICE Open Source Immunization Forecaster

Share

HLN updates COVID-19 vaccine support for Pfizer booster dose in its Award Winning ICE Open Source Immunization Forecaster

On October 25, 2021, HLN released a new version (v1.31.1) of the Immunization Calculation Engine (ICE) in support of updates to the COVID-19 vaccine. ICE is a state-of-the-art open ...

On October 25, 2021, HLN released a new version (v1.31.1) of the Immunization Calculation Engine (ICE) in support of updates to the COVID-19 vaccine. ICE is a state-of-the-art open source software system that provides clinical decision support for immunizations for use in Immunization Information Systems (IIS), Electronic Health Record (EHR), and Personal Health Record (PHR) Systems.

HLN updates COVID-19 vaccine support in its Award Winning ICE Open Source Immunization Forecaster

Share

HLN updates COVID-19 vaccine support in its Award Winning ICE Open Source Immunization Forecaster

On September 21, 2021, HLN released a new version (v1.30.1) of the Immunization Calculation Engine (ICE) in support of updates to the COVID-19 vaccine. ICE is a state-of-the-art op ...

On September 21, 2021, HLN released a new version (v1.30.1) of the Immunization Calculation Engine (ICE) in support of updates to the COVID-19 vaccine. ICE is a state-of-the-art open source software system that provides clinical decision support for immunizations for use in Immunization Information Systems (IIS), Electronic Health Record (EHR), and Personal Health Record (PHR) Systems.

Towards a National COVID-19 Vaccine Credential Strategy in the US

Share

Towards a National COVID-19 Vaccine Credential Strategy in the US

I have been monitoring the vaccine credential effort for a long time and watching various initiatives worldwide with a particular focus on what might be done in the United Stat ...

I have been monitoring the vaccine credential effort for a long time and watching various initiatives worldwide with a particular focus on what might be done in the United States. In a series of blog posts over the past several months I have described at length how the situation in the US differs from the situation in many other countries. In this post I will review the “facts on the ground” as I see them and offer a way forward for the US.